Onpattro 10 mg/5 mL (2 mg/mL) solution for intravenous infusion Images
Generic Name: patisiran
This medication has been identified as Onpattro 10 mg/5 mL (2 mg/mL) solution for intravenous infusion. It is supplied by Alnylam Pharmaceuticals, Inc.
Onpattro is used in the treatment of Transthyretin-Related Amyloidosis and belongs to the drug class miscellaneous metabolic agents. Onpattro 10 mg/5 mL (2 mg/mL) solution for intravenous infusion is not a controlled substance under the Controlled Substances Act (CSA).
Images of medication
Onpattro
- Generic Name
- patisiran
- Strength
- 10 mg/5 mL (2 mg/mL) solution for intravenous infusion
- Availability
- Prescription only
- Drug Class
- Miscellaneous metabolic agents
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Alnylam Pharmaceuticals, Inc.
- National Drug Code (NDC)
- 71336-1000
More about Onpattro (patisiran)
- Compare alternatives
- Pricing & coupons
- Drug images
- Side effects
- Dosage information
- Patient tips
- During pregnancy
- FDA approval history
- Drug class: miscellaneous metabolic agents
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.